Cancer, EarlyView.
Tag: Lung Cancer
Erratum to “JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer”
Cancer, EarlyView.
More U.S. Young Women Diagnosed With Lung Cancer at a Higher Rate Than Young Men, New Report Shows; Increase Extends to Older Women
Researchers from the American Cancer Society stress the need for strengthening cigarette smoking cessation programs
[ASAP] Enhanced Antitumor Efficacy of Novel Biomimetic Platelet Membrane-Coated Tetrandrine Nanoparticles in Nonsmall Cell Lung Cancer
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00310
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer
This randomized clinical trial compares the improvement in clinical outcomes following the administration of topotecan alone with that of berzosertib plus topotecan among patients with relapsed small cell lung cancer.
The Burden of Lung Cancer in Women Compared With Men in the US
This cross-sectional study examines the incidence rates of lung cancer in women compared with men from 2000 to 2019.
[Articles] Global variations in lung cancer incidence by histological subtype in 2020: a population-based study
AI SummaryAdenocarcinoma is now the most common type of lung cancer worldwide, especially in males. This information helps guide preventive measures in different regions.Adenocarcinoma has become the most common subtype of lung cancer globally in 2020, with incidence rates in males exceeding those of squamous cell carcinoma in most countries, and in females in all… Continue reading [Articles] Global variations in lung cancer incidence by histological subtype in 2020: a population-based study
Capturing immunotherapy response in a blood drop
AI SummaryLiquid biopsies can help identify advanced lung cancer patients who could benefit from additional drugs.Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells). When used in patients with advanced non-small cell lung cancer undergoing immunotherapy, they may identify patients… Continue reading Capturing immunotherapy response in a blood drop
Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenous
Abstract Background Lung cancer is the leading cause of cancer deaths. Screening individuals who are at elevated risk using low-dose computed tomography reduces lung cancer mortality by ≥20%. Individuals who have community-based factors that contribute to an increased risk of developing lung cancer have high lung cancer rates and are diagnosed at younger ages. In… Continue reading Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenous
Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenous
Abstract Background Lung cancer is the leading cause of cancer deaths. Screening individuals who are at elevated risk using low-dose computed tomography reduces lung cancer mortality by ≥20%. Individuals who have community-based factors that contribute to an increased risk of developing lung cancer have high lung cancer rates and are diagnosed at younger ages. In… Continue reading Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenous